During the past decade, Klinikum Herne - Urologie conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinikum Herne - Urologie" are "Urinary Bladder Neoplasms" (3 trials), "Carcinoma, Transitional Cell" (1 trials) and "Muscle-invasive Bladder Cancer" (1 trials). Many other conditions were trialed in "Klinikum Herne - Urologie" in a lesser frequency.

Most popular intervention types in "Klinikum Herne - Urologie" are "Drug" (5 trials), "Biological" (2 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Cetrelimab" (2 trials), "TAR-200" (2 trials), "Cisplatin" (1 trials) and "Conventional radiation therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Herne - Urologie" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Herne - Urologie". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Klinikum Herne - Urologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Herne - Urologie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".